News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Albany Molecular Research, Inc. (AMRI) Announces First Quarter 2010 Results
May 5, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2010.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Podcast
ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck
June 10, 2026
·
2 min read
·
Jef Akst
Manufacturing
Hikma outlines plan to invest $267M in Ohio plants, creating 350 jobs
June 9, 2026
·
1 min read
·
Nick Paul Taylor
Series B
City Therapeutics builds RNAi pipeline with $99.5M series B
June 8, 2026
·
2 min read
·
Tristan Manalac
Deals
J&J glows with $1B buyout of Firefly and its degrader platform tech
June 8, 2026
·
1 min read
·
Gabrielle Masson
